259276
2-Pentenoic acid
predominantly trans, 98%
Sinónimos:
trans-2-Pentenoic acid
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
Fórmula lineal:
C2H5CH=CHCO2H
Número CAS:
Peso molecular:
100.12
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
237-791-9
Beilstein/REAXYS Number:
1720312
MDL number:
Assay:
98%
Form:
liquid
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleQuality Level
assay
98%
form
liquid
impurities
10% cis isomer (maximum)
refractive index
n20/D 1.452 (lit.)
bp
106 °C/20 mmHg (lit.)
mp
9-11 °C (lit.)
density
0.99 g/mL at 25 °C (lit.)
functional group
carboxylic acid
SMILES string
[H]\C(CC)=C(\[H])C(O)=O
InChI
1S/C5H8O2/c1-2-3-4-5(6)7/h3-4H,2H2,1H3,(H,6,7)/b4-3+
InChI key
YIYBQIKDCADOSF-ONEGZZNKSA-N
Application
2-Pentenoic acid has been used in preparation of new nonsteroidal human androgen receptor (hAR) agonists from an hAR antagonist pharmacophore, 2(1H)-piperidino[3,2-g]quinolinone.
signalword
Danger
hcodes
Hazard Classifications
Skin Corr. 1B
Clase de almacenamiento
8A - Combustible corrosive hazardous materials
wgk
WGK 3
flash_point_f
215.6 °F - closed cup
flash_point_c
102 °C - closed cup
ppe
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
L Zhi et al.
Bioorganic & medicinal chemistry letters, 9(7), 1009-1012 (1999-05-07)
New nonsteroidal human androgen receptor (hAR) agonists were developed from an hAR antagonist pharmacophore, 2(1H)-piperidino[3,2-g]quinolinone. (+/-)-trans-7,8-Diethyl-4-trifluoromethyl-2(H)-piperidino-[3,2-g]quinoli none was synthesized and demonstrated potent hAR agonist activity (EC50=3 nM) in the cell-based cotransfection assay and high binding affinity (Ki=16 nM) in the
Maximilian Benz et al.
Nature communications, 11(1), 5391-5391 (2020-10-28)
Acceleration and unification of drug discovery is important to reduce the effort and cost of new drug development. Diverse chemical and biological conditions, specialized infrastructure and incompatibility between existing analytical methods with high-throughput, nanoliter scale chemistry make the whole drug
Norlaily Ahmad et al.
Biomacromolecules, 20(7), 2506-2514 (2019-06-28)
Inflammatory conditions are frequently accompanied by increased levels of active proteases, and there is rising interest in methods for their detection to monitor inflammation in a point of care setting. In this work, new sensor materials for disposable single-step protease